1. Home
  2. IVCA vs OPTN Comparison

IVCA vs OPTN Comparison

Compare IVCA & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVCA
  • OPTN
  • Stock Information
  • Founded
  • IVCA 2021
  • OPTN 2010
  • Country
  • IVCA Cayman Islands
  • OPTN United States
  • Employees
  • IVCA N/A
  • OPTN N/A
  • Industry
  • IVCA Blank Checks
  • OPTN Biotechnology: Pharmaceutical Preparations
  • Sector
  • IVCA Finance
  • OPTN Health Care
  • Exchange
  • IVCA Nasdaq
  • OPTN Nasdaq
  • Market Cap
  • IVCA 93.2M
  • OPTN 78.4M
  • IPO Year
  • IVCA 2022
  • OPTN 2017
  • Fundamental
  • Price
  • IVCA $11.73
  • OPTN $0.45
  • Analyst Decision
  • IVCA
  • OPTN Strong Buy
  • Analyst Count
  • IVCA 0
  • OPTN 3
  • Target Price
  • IVCA N/A
  • OPTN $3.00
  • AVG Volume (30 Days)
  • IVCA 287.0
  • OPTN 1.2M
  • Earning Date
  • IVCA 01-01-0001
  • OPTN 11-12-2024
  • Dividend Yield
  • IVCA N/A
  • OPTN N/A
  • EPS Growth
  • IVCA N/A
  • OPTN N/A
  • EPS
  • IVCA 0.26
  • OPTN N/A
  • Revenue
  • IVCA N/A
  • OPTN $75,672,000.00
  • Revenue This Year
  • IVCA N/A
  • OPTN $13.42
  • Revenue Next Year
  • IVCA N/A
  • OPTN $52.99
  • P/E Ratio
  • IVCA $45.52
  • OPTN N/A
  • Revenue Growth
  • IVCA N/A
  • OPTN 5.13
  • 52 Week Low
  • IVCA $10.96
  • OPTN $0.32
  • 52 Week High
  • IVCA $12.37
  • OPTN $2.10
  • Technical
  • Relative Strength Index (RSI)
  • IVCA 83.33
  • OPTN 39.55
  • Support Level
  • IVCA $11.70
  • OPTN $0.42
  • Resistance Level
  • IVCA $11.92
  • OPTN $0.57
  • Average True Range (ATR)
  • IVCA 0.01
  • OPTN 0.05
  • MACD
  • IVCA -0.00
  • OPTN 0.00
  • Stochastic Oscillator
  • IVCA 14.29
  • OPTN 26.39

About IVCA Investcorp India Acquisition Corp.

Investcorp AI Acquisition Corp is a blank check company.

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

Share on Social Networks: